BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 18, 2011
View Archived Issues
Academia-Fueled R&D Helps Gilead's Move into Oncology
Read More
Money Raised Year to Date
Read More
Money Raised By Biotech in 2011
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
FDA Approvals in March
Read More
Phase I Clinical Trials Update: March 2011
Read More
Phase II Clinical Trials Update: March 2011
Read More
Phase III Clinical Trials Update: March 2011
Read More
Non-U.S. Clinical Trials & Regulatory Actions: March 2011
Read More
FDA Submissions, Approvals & Other Actions: March 2011
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
Big Rewards, Bigger Risks? The Truth About Antibodies
It's no secret that monoclonal antibodies (mAbs) have been hot biotech property for a while.
Read More
IPO Pricing, Shares Offered: It's a Numbers Game
Read More